RecallDepth
Class III Terminated

Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30

This recall has been terminated (originally issued February 15, 2017).

Company
Dr. Reddy'S Laboratories, Inc.
Recall Initiated
October 13, 2016
Posted
February 15, 2017
Recall Number
D-0468-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
5,904 bottles
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.

Distribution

US Nationwide

Lot / Code Info

C500202

More recalls by Dr. Reddy'S Laboratories, Inc.

View all recalls by this company →

Other recent Class III Drug recalls